Clinical Trial Update: Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on the use of platinum-based chemotherapy for residual triple-negative breast cancer after neoadjuvant therapy, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Estrogen Receptor Negative, HER2/Neu Negative | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-10-05